Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$75,000.00

Moving past allergy: how histamine impacts infection by a multidrug resistant pathogen

FY 2019-20

Summary
Histamine is a potent chemical mediator that is commonly known for its function in allergy, but also plays an important role in the immune response. Upon exposure to an allergen, injury, or foreign invader, immune cells such as mast cells and basophils are triggered to release histamine and other inflammatory molecules. Histamine has a number of diverse biological effects, many of which are associated with allergy symptoms, including enhancing mucus production and thickness, increasing blood vessel leakage, and inducing airway constriction. Increasing blood vessel leakage is a crucial early step in the immune response, as it allows immune cells to escape into the damaged tissue to directly engage the perceived threat. Interestingly, some bacteria are also capable of producing and releasing histamine during infection. Acinetobacter baumannii is an emerging hospital-associated pathogen that is not only often extensively resistant to antibiotics, but also has been shown to release histamine. In A. baumannii, histamine appears to be produced as a key precursor of acinetobactin, a small iron-binding molecule that helps the bacteria capture this essential growth-promoting metal. The goal of this project is to understand how histamine availability impacts the outcome of A. baumannii pneumonia and bloodstream infections. We hypothesize that histamine may actually worsen A. baumannii infection by enhancing the ability of the bacteria to obtain iron and by allowing them to hijack the local immune response, using congested airways and disrupted blood vessels to avoid clearance and promote spread within the body. By defining the role of histamine in A. baumannii infection, we will not only enhance our understanding of how this bacterium is able to cause disease, but also may uncover a potential avenue for treatment using preexisting antihistamine-based therapeutics.
Program
CIHR Fellowship
Location
Tennessee, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
412864
Name
Sheldon Jessica
Region
Tennessee
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Moving past allergy: how histamine impacts infection by a multidrug resistant pathogen
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Acinetobacter Baumannii; Bacteremia; Histamine; Innate Immunity; Iron; Mast Cell; Metal Acquisition; Pathogenesis; Pneumonia; Siderophore
Abstract
Histamine is a potent chemical mediator that is commonly known for its function in allergy, but also plays an important role in the immune response. Upon exposure to an allergen, injury, or foreign invader, immune cells such as mast cells and basophils are triggered to release histamine and other inflammatory molecules. Histamine has a number of diverse biological effects, many of which are associated with allergy symptoms, including enhancing mucus production and thickness, increasing blood vessel leakage, and inducing airway constriction. Increasing blood vessel leakage is a crucial early step in the immune response, as it allows immune cells to escape into the damaged tissue to directly engage the perceived threat. Interestingly, some bacteria are also capable of producing and releasing histamine during infection. Acinetobacter baumannii is an emerging hospital-associated pathogen that is not only often extensively resistant to antibiotics, but also has been shown to release histamine. In A. baumannii, histamine appears to be produced as a key precursor of acinetobactin, a small iron-binding molecule that helps the bacteria capture this essential growth-promoting metal. The goal of this project is to understand how histamine availability impacts the outcome of A. baumannii pneumonia and bloodstream infections. We hypothesize that histamine may actually worsen A. baumannii infection by enhancing the ability of the bacteria to obtain iron and by allowing them to hijack the local immune response, using congested airways and disrupted blood vessels to avoid clearance and promote spread within the body. By defining the role of histamine in A. baumannii infection, we will not only enhance our understanding of how this bacterium is able to cause disease, but also may uncover a potential avenue for treatment using preexisting antihistamine-based therapeutics.
Competitiondate
201910
Approvedterm2
1 yr 6 mths
Pinamesdelim
Sheldon, Jessica
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $75,000~ $0~
Direct Payment - $75,000 Grant (2019-20) | Canada Spends